World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
104
Citations
86434
World Ranking
6874
National Ranking
663

Overview

Kausik K. Ray is affiliated with Imperial College London in the United Kingdom. Their research primarily spans the field of Medicine, with significant contributions in Surgery, Economics and Econometrics, Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine, and Cancer Research.

The main topics of their work focus on:

  • Lipoproteins and Cardiovascular Health
  • Health Systems, Economic Evaluations, Quality of Life
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • Cancer, Lipids, and Metabolism
  • Pharmaceutical Economics and Policy
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Diabetes Treatment and Management

Their frequent co-authors include:

  • Alberico L. Catapano
  • Frederick J. Raal
  • Gregory G. Schwartz
  • Lawrence A. Leiter
  • Wolfgang Köenig

They have published extensively in multiple scientific journals. The most common publication venues are:

  • Atherosclerosis
  • European Heart Journal
  • Journal of the American College of Cardiology
  • Journal of Clinical Lipidology
  • Circulation

Representative recent papers authored or co-authored by Kausik K. Ray include:

  • 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice, 2021, European Heart Journal
  • 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation, 2020, European Heart Journal
  • Two Phase 3 Trials of Inclisiran in Patients with Elevated LDL Cholesterol, 2020, New England Journal of Medicine
  • Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel, 2020, European Heart Journal
  • Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease, 2020, New England Journal of Medicine

The research output of Kausik K. Ray reflects a multidisciplinary approach, incorporating clinical, metabolic, and economic perspectives in cardiovascular and metabolic diseases.

Best Publications

  • 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular riskThe Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)

    François Mach;Colin Baigent;Alberico L Catapano;Konstantinos C Koskinas

  • Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies

    N Sarwar;P Gao;Seshasai Srk.

  • Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus

    Benjamin M. Scirica;Deepak L. Bhatt;Deepak L. Bhatt;Eugene Braunwald;P. Gabriel Steg

  • 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice

    Frank L J Visseren;François Mach;Yvo M Smulders;David Carballo

  • Major lipids, apolipoproteins, and risk of vascular disease

    E Di Angelantonio;N Sarwar;P Perry

  • Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel

    Brian A Ference;Henry N Ginsberg;Ian T. Graham;Kausik K Ray

  • Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials

    Naveed Sattar;David Preiss;Heather M Murray;Paul Welsh

  • Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society

    Borge G. Nordestgaard;M. John Chapman;Steve E. Humphries;Henry N. Ginsberg

  • Lipoprotein(a) as a cardiovascular risk factor: current status

    Børge G. Nordestgaard;M. John Chapman;Kausik Ray;Jan Borén

  • Risk of Incident Diabetes With Intensive-Dose Compared With Moderate-Dose Statin Therapy A Meta-analysis

    David Preiss;Sreenivasa Rao Kondapally Seshasai;Paul Welsh;Sabina A. Murphy

  • Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials.

    Kausik K Ray;Sreenivasa Rao Kondapally Seshasai;Shanelle Wijesuriya;Rupa Sivakumaran

  • Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management

    M John Chapman;Henry N Ginsberg;Pierre Amarenco;Felicita Andreotti

  • Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management

    Erik S. Stroes;Paul D. Thompson;Alberto Corsini;Georgirene D. Vladutiu

  • Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel

    Jan Borén;M. John Chapman;M. John Chapman;Ronald M. Krauss;Chris J. Packard

  • Two Phase 3 Trials of Inclisiran in Patients With Elevated LDL Cholesterol

    Kausik K. Ray;R. Scott Wright;David Kallend;Wolfgang Koenig;Wolfgang Koenig

  • Inclisiran in Patients at High Cardiovascular Risk with Elevated LDL Cholesterol.

    Kausik K Ray;Ulf Landmesser;Lawrence A Leiter;David Kallend

  • Familial Hypercholesterolaemia in Children and Adolescents: Gaining Decades of Life by Optimizing Detection and Treatment

    Albert Wiegman;Samuel S. Gidding;Gerald F Watts;M John Chapman

  • Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease.

    Deepak L. Bhatt;Michael Szarek;Bertram Pitt;Christopher P. Cannon

  • Impact of triglyceride levels beyond low-density lipoprotein cholesterol after acute coronary syndrome in the PROVE IT-TIMI 22 trial.

    Michael Miller;Christopher P. Cannon;Sabina A. Murphy;Jie Qin

  • Risk of Incident Diabetes With Intensive-Dose Compared With Moderate-Dose Statin Therapy

    David Preiss;Sreenivasa Rao Kondapally;Paul Welsh;Sabina A. Murphy

Frequent Co-Authors

Maciej Banach
Maciej Banach John Paul II Catholic University of Lublin
Christopher P. Cannon
Christopher P. Cannon Brigham and Women's Hospital
Alberico L. Catapano
Alberico L. Catapano University of Milan
John J.P. Kastelein
John J.P. Kastelein University of Amsterdam
Stephen J. Nicholls
Stephen J. Nicholls Monash University
Gerald F. Watts
Gerald F. Watts University of Western Australia
Henry N. Ginsberg
Henry N. Ginsberg Columbia University
G. Kees Hovingh
G. Kees Hovingh University of Amsterdam
Frederick J. Raal
Frederick J. Raal University of the Witwatersrand
Lawrence A. Leiter
Lawrence A. Leiter University of Toronto

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine doesn’t always mean medical school. Today, online degrees offer flexible pathways into healthcare professions that support patients and the healthcare system. If you’re passionate about mental health, consider the fastest psych np program options that allow registered nurses to advance quickly into psychiatric nurse practitioner roles through online study.

Those interested in the business side of healthcare can pursue a bachelors in healthcare administration. This degree provides a strong foundation in healthcare management, policy, and organizational leadership, all accessible through affordable online programs.

If you already hold a relevant undergraduate degree, a master’s is the next step. The cheapest mha programs online healthcare can help you gain essential skills for administrative and leadership positions without a hefty financial burden.

For nursing professionals aiming for the highest level of clinical practice, the most affordable dnp programs make it easier to earn a Doctor of Nursing Practice through flexible, cost-effective online study. These varied online degree options open up numerous career pathways beyond traditional medical education.

Best Scientists Citing Kausik K. Ray

Trending Scientists

Recently Published Articles